Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy -: Comment

被引：0
|
作者：
Emery, P [1 ]
机构：
[1] Leeds Teaching Hosps Trust, Acad Unit Musculoskeletal Dis, Chapel Allerton Hosp, Leeds LS7 4SA, W Yorkshire, England
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2005年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：768 / 768
页数：1
相关论文
共 50 条
  • [1] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy
    Genovese, MC
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 767 - 768
  • [2] Response to pneumococcal vaccine in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy treated with abatacept in the arrive trial
    Schiff, M.
    Kaell, A.
    Tay, L.
    Vratsanos, G.
    Bahrt, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 437 - 437
  • [3] The safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Schiff, M.
    Pritchard, C.
    Teng, J.
    Bahrt, K.
    Genovese, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 89 - 89
  • [4] Sustained improvements through 18 months with abatacept in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy.
    Genovese, M
    Luggen, M
    Schiff, M
    Sherrer, Y
    Sen, K
    Aranda, R
    Beckers, JC
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4064 - 4064
  • [5] Abatacept increases activity levels in rheumatoid arthritis patients with inadequate responses to methotrexate or anti-TNF therapy
    Westhovens, R
    Schiff, M
    Dougados, M
    Ge, Z
    Nuamah, I
    Li, T
    Russell, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 398 - 398
  • [6] The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Emery, P.
    Pritchard, C.
    Zhou, X.
    Genovese, M.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II45 - II45
  • [7] Time to treatment response with abatacept in patients with RA and an inadequate response to Anti-TNF therapy
    Schiff, M.
    Dougados, M.
    Le Bars, M.
    Lafosse, C.
    Koncz, T.
    Genovese, M. C.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S307 - S308
  • [8] Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data
    Dougados, M.
    Wells, G.
    Schmidely, N.
    Le Bars, M.
    van Riel, P.
    Aletaha, D.
    Schiff, M.
    Smolen, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 258 - 260
  • [9] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Hirabara, Shinya
    Takahashi, Nobunori
    Fukaya, Naoki
    Miyake, Hiroyuki
    Yabe, Yuichiro
    Kaneko, Atsushi
    Ito, Takayasu
    Oguchi, Takeshi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Sugiura, Fumiaki
    Hayashi, Masatoshi
    Funahashi, Koji
    Hanabayashi, Masahiro
    Asai, Shuji
    Ishiguro, Naoki
    Kojima, Toshihisa
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1247 - 1254
  • [10] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Shinya Hirabara
    Nobunori Takahashi
    Naoki Fukaya
    Hiroyuki Miyake
    Yuichiro Yabe
    Atsushi Kaneko
    Takayasu Ito
    Takeshi Oguchi
    Daihei Kida
    Yuji Hirano
    Takayoshi Fujibayashi
    Fumiaki Sugiura
    Masatoshi Hayashi
    Koji Funahashi
    Masahiro Hanabayashi
    Shuji Asai
    Naoki Ishiguro
    Toshihisa Kojima
    Clinical Rheumatology, 2014, 33 : 1247 - 1254
12345